Session 1 - COVID, Viruses and Allergy
February 22, 2022
7:30-10:30 am CST 

Intro & Welcome
Bruce Bochner, MD

7:30-8:10 am
Keynote: Harnessing the innate immune response in the treatment of COVID-19
Professor Sir Stephen T Holgate CBE, FMedSci

8:10-8:25 am
Human surfactant protein D binds spike protein and acts as an entry inhibitor of SARS-CoV-2 pseudotyped viral particles
Miao-Hsi Hsieh
Abstract #7

8:26-8:41
Risk factors for severe COVID-19 disease in asthmatic patients
Harold Renz, MD
Abstract #26

8:42-8:57 am
SARS-CoV-2 infection in pregnancy alters maternal and cord blood immune phenotype at delivery
Jesica A. Breznik, PhD
Abstract #57

8:58-9:08 am
BREAK

9:09-9:24 am
IL-5 enhances human mast cell interferon responses to viral infection
Jean S. Marshall, PhD
Abstract #48

9:25-9:40 am
COVID-19 patients display dysregulated expression of CD48 activating and CD300a inhibitory receptors: a hint to its etiopathogenesis?
Francesca Levi-Schaffer, PhD
Abstract #41

9:41-9:56 am
Cutaneous and systemic hyperinflammation: a potential driver of maculopapular drug exanthema in severely ill COVID-19 patients
Marie-Charlotte Brüggen
Abstract #23

9:57-10:12 am
Variability of responsiveness to the BNT162b2 mRNA COVID-19 vaccine received during wildfire smoke exposure is associated with altered Natural Killer (NK) cell phenotype changes 
Gursharan Kaur Sanghar, BS
Abstract #50

10:13-10:15 am
Closing Remarks
Bruce Bochner, MD

© 2023 Collegium Internationale Allergologicum. All rights reserved.
Privacy Notice | Website Terms of Use